IBNSINA PHARMA EGX:ISPH:
IBNSINA PHARMA Q1 CONSOL NET PROFIT ATTRIBUTABLE EGP 181.9 MILLION
IBNSINA PHARMA Q1 CONSOL NET SALES EGP 17.04 BILLION
Ibnsina Pharma Q1 Consol Net Profit EGP 181.9 Million
Later from Ibnsina Pharma
- Ibnsina Pharma Board Approves Appraiser Reports Of Shorouk Specialized Hospital
- Ibnsina Pharma Q2 Consol Profit EGP 206.9 Million
- SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
- Ibnsina Pharma FY Dividend Per Share EGP 0.16
- SNG: Egypt: Ibnsina Pharma to disburse $0.0033/share cash dividend in October
Follow Ibnsina Pharma into a list and get an email when it puts out news.
Follow Ibnsina Pharma